Search

everythinglearnresearchcommunity

for

Search:↓

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Mesenchymal stem cells, especially injected into the skin, heal wounds faster and better than chitosan gel or other treatments.

The hepatitis B vaccine did not cause hair loss in the tested mice.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Telomere damage affects skin and hair follicle stem cells by messing up important growth signals.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Injectable gelatin microspheres with platelet-rich plasma speed up wound healing.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

Some congenital hair disorders improve with age and can be managed with treatments like minoxidil, retinoids, supplements, and gentle hair care, but there's no cure.